Return On Equity of Corvus Pharmaceuticals, Inc. from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Corvus Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • Corvus Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -26%, a 85% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. annual Return On Equity for 2024 was -192%, a 223% decline from 2023.
  • Corvus Pharmaceuticals, Inc. annual Return On Equity for 2023 was -60%, a 5% decline from 2022.
  • Corvus Pharmaceuticals, Inc. annual Return On Equity for 2022 was -57%, a 29% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Corvus Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -26% +142% +85% 01 Jul 2025 30 Sep 2025
Q2 2025 -103% -49% -92% 01 Apr 2025 30 Jun 2025
Q1 2025 -114% -54% -90% 01 Jan 2025 31 Mar 2025
Q4 2024 -192% -133% -223% 01 Oct 2024 31 Dec 2024
Q3 2024 -168% -107% -176% 01 Jul 2024 30 Sep 2024
Q2 2024 -54% +17% +24% 01 Apr 2024 30 Jun 2024
Q1 2024 -60% +5% +8.3% 01 Jan 2024 31 Mar 2024
Q4 2023 -60% -3% -5% 01 Oct 2023 31 Dec 2023
Q3 2023 -61% -12% -24% 01 Jul 2023 30 Sep 2023
Q2 2023 -71% -32% -81% 01 Apr 2023 30 Jun 2023
Q1 2023 -65% -24% -59% 01 Jan 2023 31 Mar 2023
Q4 2022 -57% -13% -29% 01 Oct 2022 31 Dec 2022
Q3 2022 -49% -42% -578% 01 Jul 2022 30 Sep 2022
Q2 2022 -39% -32% -419% 01 Apr 2022 30 Jun 2022
Q1 2022 -41% -34% -476% 01 Jan 2022 31 Mar 2022
Q4 2021 -44% -33% -314% 01 Oct 2021 31 Dec 2021
Q3 2021 -7% +72% +91% 01 Jul 2021 30 Sep 2021
Q2 2021 -8% +62% +89% 01 Apr 2021 30 Jun 2021
Q1 2021 -7% +57% +89% 01 Jan 2021 31 Mar 2021
Q4 2020 -11% +44% +81% 01 Oct 2020 31 Dec 2020
Q3 2020 -79% -31% -63% 01 Jul 2020 30 Sep 2020
Q2 2020 -70% -26% -60% 01 Apr 2020 30 Jun 2020
Q1 2020 -64% -25% -64% 01 Jan 2020 31 Mar 2020
Q4 2019 -55% -17% -44% 01 Oct 2019 31 Dec 2019
Q3 2019 -48% -7% -17% 01 Jul 2019 30 Sep 2019
Q2 2019 -44% +2% +4.7% 01 Apr 2019 30 Jun 2019
Q1 2019 -39% +13% +24% 01 Jan 2019 31 Mar 2019
Q4 2018 -38% +17% +31% 01 Oct 2018 31 Dec 2018
Q3 2018 -41% +7% +15% 01 Jul 2018 30 Sep 2018
Q2 2018 -46% -4% -8.6% 01 Apr 2018 30 Jun 2018
Q1 2018 -51% -18% -52% 01 Jan 2018 31 Mar 2018
Q4 2017 -55% -30% -121% 01 Oct 2017 31 Dec 2017
Q3 2017 -49% -19% -62% 01 Jul 2017 30 Sep 2017
Q2 2017 -42% 01 Apr 2017 30 Jun 2017
Q1 2017 -34% 01 Jan 2017 31 Mar 2017
Q4 2016 -25% 01 Oct 2016 31 Dec 2016
Q3 2016 -30% 01 Jul 2016 30 Sep 2016

Corvus Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -192% -133% -223% 01 Jan 2024 31 Dec 2024
2023 -60% -3% -5% 01 Jan 2023 31 Dec 2023
2022 -57% -13% -29% 01 Jan 2022 31 Dec 2022
2021 -44% -33% -314% 01 Jan 2021 31 Dec 2021
2020 -11% +44% +81% 01 Jan 2020 31 Dec 2020
2019 -55% -17% -44% 01 Jan 2019 31 Dec 2019
2018 -38% +17% +31% 01 Jan 2018 31 Dec 2018
2017 -55% -30% -121% 01 Jan 2017 31 Dec 2017
2016 -25% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.